Sign in

CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company

Azora Therapeutics, Inc. (DE)

Sign in to watch
Ticker
AZR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
800667150
Phone
434-422-9800
Business address
16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
Former names
ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 4 Conversion President and CEO acquired 626,252 shares (conversion)
  5. 4 Conversion Chief Strategy Officer acquired 626,252 shares (conversion)
  6. 4 Insider Changes in Ownership
  7. 4 Grant or award President and CEO acquired 232,417 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy 10% owner bought 3,233 shares at an average $2.69 ($8,691)
  12. 4 Open-market buy 10% owner bought 11,753 shares at an average $2.78 ($32,638)
  13. 4 Open-market buy 10% owner bought 25,000 shares at $2.60 ($65,000)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Grant or award Chief Development Officer acquired 299,414.43 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Grant or award Chief Operating Officer acquired 26,510 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 1 of 7 · 123 filings